Loading data
PAYNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.2 bn USD | 871.75 m USD | 614.49 m USD | 497 m USD | 395.52 m USD |
| Cost of revenue | 900.17 m USD | 633.58 m USD | 432.15 m USD | 347.32 m USD | 274.14 m USD |
| Gross profit | 296.34 m USD | 238.17 m USD | 182.34 m USD | 149.68 m USD | 121.38 m USD |
| Research and development expense | 61.47 m USD | 51.33 m USD | 44.25 m USD | 41.22 m USD | 34.12 m USD |
| Operating profit | 75.54 m USD | 44.86 m USD | 18.09 m USD | -2.98 m USD | 10.37 m USD |
| Profit before tax | 85.28 m USD | 53.94 m USD | 25.12 m USD | -1.31 m USD | 10.37 m USD |
| Income tax expense | 18.34 m USD | 9.78 m USD | 2.8 m USD | -795 k USD | 1.07 m USD |
| Net income (reported basis) | 66.9 m USD | 44.2 m USD | 22.3 m USD | -513 k USD | 9.3 m USD |
| Net income attributable to common shareholders | — | — | 22.32 m USD | -513 k USD | 7.04 m USD |
| Basic earnings per share | 0.53 USD/share | 0.36 USD/share | 0.18 USD/share | 0 USD/share | 0.06 USD/share |
| Diluted earnings per share | 0.52 USD/share | 0.35 USD/share | 0.18 USD/share | 0 USD/share | 0.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.